CELLTRION

Celltrion, Inc.

Application Filed: 2011-04-01
Trademark Application Details
Trademark Logo CELLTRION

The mark consists in a figure of three green circles and the word "CELLTRION" in black, in which said three green circles have a thin-lined circle, a thick-lined circle and a solid circle.

Mark For: CELLTRION® trademark registration is intended to cover the categories of [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]. [all]

>The color(s) black, green is/are claimed as a feature of the mark. The mark consists in a figure of three green circles and the word "CELLTRION" in black, in which said three green circles have a thin-lined circle, a thick-lined circle and a solid circle.

Status

2020-06-01 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number79101488
Registration Number4169803
Mark Literal ElementsCELLTRION
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeTRADEMARK. SERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Affidavit TextSECTION 71
Current LocationNot Found 2018-07-20
Basis66(a)
Class StatusSECTION 71 - CANCE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentYes
Current BasisNo
No BasisNo
Cancellation CodeG
Attorney NameKisuk Lee
Attorney Docket Number15234-200009
Law Office AssignedM60
Employee NameCOLEMAN, NICHOLAS A

Timeline

2011-04-01Application Filed
2012-04-24Published
2012-04-24Published for Opposition
2012-07-10Trademark Registered
2018-07-20Location:
2018-07-20Location: Not Found
2018-07-20Status: A partial Section 71 declaration has been accepted.
2018-07-20Status: Live/Registered
2019-04-19Transaction Date
2021-07-10Maintenance Early File Date
2022-07-11Maintenance On Time Date
2023-01-10Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: CELLTRION, INC.
Address23, Academy-ro, Yeonsu-gu Incheon KOREA, REPUBLIC OF 406-840
Legal Entity TypeCorporation
Legal Entity StateKOREA, REPUBLIC OF

Design Search Codes

26.01.15Circles, exactly three circles; Three circles
26.01.21Circles that are totally or partially shaded.
260102Circles, plain single line; Plain single line circles
260115Circles, exactly three circles; Three circles
260121Circles that are totally or partially shaded.

Attorney of Record

Kisuk Lee
Harness, Dickey & Pierce, PLC
7700 Bonhomme Ave, Suite 400
St. Louis, MO 63105-0032

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
IC 035. US 100 101 102. G & S: Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
IC 040. US 100 103 106. G & S: Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
IC 042. US 100 101. G & S: Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ](CANCELLED)
IC 044. US 100 101. G & S: [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:35
U.S. Codes:100,101,102
International Codes:40
U.S. Codes:100,103,106
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
B00001Page 2, line 28 through 30, "medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others" should be deleted in class 42.

Assignments

Trademark Filing History

DescriptionDateProceeding Number
PARTIAL INVALIDATION PROCESSED BY THE IB2019-04-19
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB2019-03-23
INVALIDATION PROCESSED2019-03-2372629
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED2019-03-20
REGISTERED - PARTIAL SEC 71 ACCEPTED2018-07-2075461
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED2018-07-20
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2018-07-1875461
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2018-06-21
TEAS SECTION 71 RECEIVED2018-06-21
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED2017-07-10
CHANGE OF NAME/ADDRESS REC'D FROM IB2015-03-26
LIMITATION FROM THE IB EXAMINED AND ENTERED2013-10-1172589
CERTIFICATE OF CORRECTION ISSUED2013-10-1176293
ASSIGNED TO PARALEGAL2013-10-1176293
LIMITATION OF GOODS RECEIVED FROM IB2013-08-30
NOTIFICATION PROCESSED BY IB2012-12-02
FINAL DECISION TRANSACTION PROCESSED BY IB2012-11-04
FINAL DISPOSITION PROCESSED2012-10-1667445
FINAL DISPOSITION NOTICE SENT TO IB2012-10-16
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2012-10-10
REGISTERED-PRINCIPAL REGISTER2012-07-10
PUBLISHED FOR OPPOSITION2012-04-24
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2012-04-24
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB2012-04-04
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2012-04-04
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB2012-04-04
LAW OFFICE PUBLICATION REVIEW COMPLETED2012-03-1974221
ASSIGNED TO LIE2012-03-1974221
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2012-03-026328
EXAMINERS AMENDMENT E-MAILED2012-03-026328
EXAMINERS AMENDMENT -WRITTEN2012-03-0285330
EXAMINER'S AMENDMENT ENTERED2012-03-0288888
APPROVED FOR PUB - PRINCIPAL REGISTER2012-03-02
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2011-12-15
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2011-12-15
REFUSAL PROCESSED BY IB2011-10-18
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2011-09-23
REFUSAL PROCESSED BY MPU2011-09-2272589
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2011-09-22
NON-FINAL ACTION WRITTEN2011-09-2185330
APPLICATION FILING RECEIPT MAILED2011-09-13
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2011-09-09
ASSIGNED TO EXAMINER2011-09-0985330
SN ASSIGNED FOR SECT 66A APPL FROM IB2011-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed